Theatre 14

Tuesday 26th March

Wednesday 27th March


11.00 - 11.30

Larry Sitka

Enterprise Imaging, The First Step to a Learning Health System

Demand for data, information and knowledge is growing exponentially. Data consolidation, and bringing all relevant information from across the enterprise to the point of care, in the context of the patient and to use this knowledge to affect the outcome are the keyfuture challenges.  This requires and enterprise imaging solutions that goes beyond the current storage centric approach and acts more like a “service bus”, that allows the integration a multitude of sources, the enrichment of information in a meaningful way and the orchestration of information flows across silo’s. Learn how this new approach creates freedom to use best-of-breed solutions, enables future use of artificial intelligence and reduces costs.


11.45 - 12.15

Dr Andrew Bagshaw

Multimodal Neuroimaging: Methods and Applications of Combined EEG-fMRI

Functional MRI (fMRI) and electroencephalography (EEG) are two of the most widely used techniques for studying human brain function, and are based on changes in haemodynamic and electrophysiological activity respectively. While each provides a crucial window into brain function, combining them has the potential to give more detailed spatiotemporal information. The advantages and disadvantages of combined EEG-fMRI will be discussed, along with applications in basic and clinical neuroscience.


12.30 - 13.00

Wai Lup Wong

PET CT in the Surveillance of People with Head and Neck Cancer

Drawing from a survey of the published literature, the seminar will provide a review of the current role of FDG PET/CT following chemo-radiotherapy in people with advanced head and neck cancer. It will also give an update on the emerging role of FDG PET/CT in the follow-up of other people with head and neck cancer.


13.15 - 13.45

Peter Ross

Improving Quality of Diagnostic PET-CT Reporting: Factors Influencing Doctors’ Performance.

The seminar provides a unique overview of standards of diagnostic reporting in PET-CT in England between 2010 to 2016. By empirically measuring rates of discrepancy and correlating it to the results of attitudinal survey data, the findings shed light on the factors to influence clinical performance and in particular the association between the level of doctors’ engagement and clinical performance.


14.00 - 14.30

Iris Asllani

Multimodal Functional Imaging of the Diseased Brain

The primary goal of clinical MRI is the development of effective biomarkers that can distinguish the diseased brain from its normal counterpart in early stages. To this end, several methods have been developed that can measure various aspects of the brain’s structure and function. This talk will focus on recent efforts to integrate these methods, including non-MRI based ones, to provide a comprehensive and quantitative assessment of the diseased brain.


14.45 - 15.15

David Omiyi

Artificial Intelligence - the future of medical imaging

Today, one of the biggest problems facing health professionals in general is the overload of too much patient information to sift through. Artificial intelligence (AI) has captured the imagination and attention of doctors over the past couple years as several hospitals work to perfect these systems for clinical use. The use of AI is not left of in Medical Imaging, this seminar will cover the current trends and applications of AI in healthcare imaging and diagnosis.


15.30 - 16.00

Matthew Gardner

Patient dosimetry audit for nuclear medicine and radiotherapy planning CT

Patient dosimetry audit is well established in diagnostic radiology, but much less so in other areas where CT is used such as nuclear medicine and radiotherapy. With recent publications of national data to compare against there is now an onus to address this. The seminar will focus on local efforts to implement a patient dosimetry system for CT in nuclear medicine and radiotherapy, including the challenges encountered, solutions and results.